Baboon-to-human liver transplantation.

PubWeight™: 4.01‹?› | Rank: Top 1%

🔗 View Article (PMC 2962592)

Published in Lancet on January 09, 1993

Authors

T E Starzl1, J Fung, A Tzakis, S Todo, A J Demetris, I R Marino, H Doyle, A Zeevi, V Warty, M Michaels

Author Affiliations

1: Pittsburgh Transplant Institute, Pennsylvania.

Articles citing this

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Liver regeneration. J Cell Physiol (2007) 6.69

Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol (2009) 3.55

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol (1998) 2.10

Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev (2001) 2.08

Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation (2010) 1.64

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology (2009) 1.54

Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51

Effect of donor age and sex on the outcome of liver transplantation. Hepatology (1995) 1.31

Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation (1994) 1.21

Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses (1998) 1.05

Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants. J Med Virol (1995) 1.03

Prospects of clinical xenotransplantation. Transplant Proc (1994) 0.98

Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol Rev (2014) 0.97

Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation (1994) 0.97

Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation (1997) 0.95

Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl (1997) 0.94

Infectious disease issues in xenotransplantation. Clin Microbiol Rev (2001) 0.91

A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) (2012) 0.91

Paediatric lung transplantation: the agony and the ecstasy. Thorax (1994) 0.90

Molecular mechanism of size control in development and human diseases. Cell Res (2011) 0.88

Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol (2001) 0.86

Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. PLoS One (2013) 0.86

Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc (1995) 0.85

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev (1993) 0.84

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice. Am J Pathol (1995) 0.83

Renal dysfunction associated with liver transplantation. Postgrad Med J (1995) 0.83

Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol (1995) 0.83

Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation (1996) 0.82

Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol (2013) 0.82

Follow up of infection of chacma baboons with inoculum containing A and non-A genotypes of hepatitis B virus. World J Gastroenterol (2003) 0.81

Human liver xenotransplantation. Xeno (1993) 0.81

Animal organs for human transplantation: how close are we? Proc (Bayl Univ Med Cent) (2000) 0.80

The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-to-Baboon Liver Xenotransplantation. Am J Transplant (2016) 0.80

Developments in liver transplantation. Gut (2004) 0.79

Clinical xenotransplantation. Xenotransplantation (1994) 0.78

Baboon-to-human liver transplantation. Lancet (1993) 0.78

Will xenotransplantation ever be feasible? J Am Coll Surg (1998) 0.78

A brief history of clinical xenotransplantation. Int J Surg (2015) 0.78

How does a single cell know when the liver has reached its correct size? PLoS One (2014) 0.77

Human-to-baboon bone marrow transplantation after conditioning with nonlethal irradiation. Transplant Proc (1994) 0.77

Heteroagglutinins and their significance in baboon hepatic xenotransplantation. Transplantation (1995) 0.76

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76

Choice of cyclophosphamide dose in baboon-to-human liver transplantation. Lancet (1993) 0.75

Chimerism and xenotransplantation. New concepts. Surg Clin North Am (1999) 0.75

The donor lung: conservation of a precious resource. Thorax (1998) 0.75

Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75

Changes in biliary (high-molecular-mass) and liver isoforms of alkaline phosphatase after baboon-to-human liver transplantation. Clin Chem (1994) 0.75

Clinical trials and projected future of liver xenotransplantation. World J Surg (1997) 0.75

New Phase of Growth for Xenogeneic-Based Bioartificial Organs. Int J Mol Sci (2016) 0.75

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

Proteomic analysis of domestic pig pancreas during development using two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Lab Anim Res (2014) 0.75

Controversies in patient selection for liver transplantation. West J Med (1993) 0.75

Baboon pancreatic islet isolation and transplantation. Transplant Proc (1994) 0.75

GRG profiles: Professor Ignazio Marino. Dig Dis Sci (2014) 0.75

Articles cited by this

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES. Transplantation (1964) 2.78

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. N Engl J Med (1990) 2.23

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Baboon-to-human cardiac xenotransplantation in a neonate. JAMA (1985) 1.98

Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation (1993) 1.94

Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation (1992) 1.68

Outcome of HIV infection in transplant patient on cyclosporin. Lancet (1991) 1.66

Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Natl Acad Sci U S A (1992) 1.50

Transplantation in HIV+ patients. Transplantation (1990) 1.29

The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation (1991) 1.24

BABOON RENAL GRAFTS. JAMA (1964) 1.23

Qualitative testing for circulating immune complexes by use of zone electrophoresis on agarose. Clin Chem (1980) 1.22

Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass. S Afr Med J (1977) 1.14

Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc (1993) 1.03

Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc (1992) 1.01

Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections. Hepatology (1990) 0.95

Fourth component of complement (C4) polymorphism in human orthotopic liver transplantation. Transplantation (1985) 0.94

Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. Transplant Proc (1993) 0.93

The nucleotide sequences of baboon chorionic gonadotropin beta-subunit genes have diverged from the human. Gene (1986) 0.93

Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc (1993) 0.90

Normal biochemistry values in baboons (Papio C. cinocephalus). Comp Biochem Physiol B (1990) 0.87

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Racial discrimination in the allocation of distinction awards? Analysis of list of award holders by type of award, specialty and region. BMJ (1998) 12.93

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Kidney transplantation under FK 506. JAMA (1990) 7.45

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Liver transplantation (1). N Engl J Med (1989) 4.53

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Characterization and localization of the even-skipped protein of Drosophila. EMBO J (1987) 3.29

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Liver transplantation (2). N Engl J Med (1989) 2.93

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc (2000) 2.89

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82

Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet (1997) 2.81

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75

The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care (1993) 2.70

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66

The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60